The biotech firm has moved to a new facility at Abingdon Science Park, expanding its laboratory and tissue culture ...
Research is exploring how redesigned compounds could retain therapeutic potential while reducing hallucinations and other ...
A pharmaceutical team may consider a combination product nearly ready because the clinical, stability, quality, and drug data ...
CARBOGEN AMCIS hosted a two-day ISPE workshop in Switzerland, bringing industry experts together to discuss containment, ...
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at ...
The pharma giant is migrating its enterprise-wide SAP systems to a private cloud environment to streamline global operations ...
With artificial intelligence (AI) moving from experimentation into regulated environments, pharmaceutical manufacturers must ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results